All Nippon Airways will cooperate with Joby, an enterprise invested by Toyota, on the flying car business, which is planned to be practical in 2025

Clinical CRO Tigermed: The ‘Small and Beautiful’

In this race of pharmaceutical R&D outsourcing segment, WuXi AppTec, Pharmaron, Tigermed and Asychem are some of the major names – but which has a truly winning side?

Momenta says it is first Chinese company with Germany-wide L4 testing permit

Momenta Global Limited（Momenta，初速度科技）said on July 29 that it had received authorization from Germany’s Federal Motor Transport Authority, or KBA, to test Level 4 autonomous-driving systems on urban roads across the country. The Hong Kong-listed company said it was the first Chinese enterprise to obtain a German L4 testing permit with nationwide urban-road coverage.

CRO ClinChoice Raises USD 150 Mn in Series E Round

2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.

CRO Giant Tigermed’s 1H 2020 Net Profits Up 98%

Chinese CRO industry is setting off – the continued pandemic may bring the most potential to this industry.

WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell

According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index.  It has been considered a top holding by many MSCI China indexes for some time.